Nuclear factor-kappa B (NF-kappa B) is the generic name of a family of transcription factors that function as dimers and regulate genes involved in immunity, inflammation and cell survival.
There are several pathways leading to NF-kappa B-activation.
As shown in the following picture, the canonical NF-kappa B pathway is induced by tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1) or byproducts of bacterial and viral infections. This pathway relies on IKK- mediated IkappaB-alpha phosphorylation on Ser32 and 36, leading to its degradation, which allows the p50/p65 NF-kappa B dimer to enter the nucleus and activate gene transcription.
Atypical pathways are IKK-independent and rely on phosphorylation of IkappaB-alpha on Tyr42 or on Ser residues in IkappaB-alpha PEST domain. The non-canonical pathway is triggered by particular members of the TNFR superfamily, such as lymphotoxin-beta (LT-beta) or BAFF. It involves NIK and IKK-alpha-mediated p100 phosphorylation and processing to p52, resulting in nuclear translocation of p52/RelB heterodimers.
All in all, the NF-κB signaling pathway is involved in pathological processes such as infection, inflammation, immune response, apoptosis, and tumor, as well as cell cycle regulation and cell differentiation through target gene expression products. Adaptor proteins recruit the IKK complex which phosphorylates and degrades IκB, allowing NF-κB to translocate to the nucleus. Dysregulation of NF-κB signaling can lead to inflammatory and autoimmune disease and cancer.
When NF-κB is translocated into the nucleus, it binds to the NF-κB binding motif 5'-GGGRNNYYCC-3' on the target gene promoter or enhancer, and induces transcription of many factors.
These factors include cytokines (TNF-α, IFN-beta, IL-1beta, IL-2, IL-3 and IL-6, etc.), chemokines (IL-8, RANTES, MCP-1), adhesion molecules (E-selectin, ICAM-1 and VCAM-1), acute response protein, complement, growth factor (GM-CSF, G-CSF and M-CSF ) and transcription factors and so on.
|LTA||LTA Antibody||LTA Protein||LTA cDNA||LTA ELISA Kit|
|LTB||LTB Antibody||LTB Protein||LTB cDNA||LTB ELISA Kit|
|LTBR||LTBR Antibody||LTBR Protein||LTBR cDNA||LTBR ELISA Kit|
|LY96||LY96 Antibody||LY96 Protein||LY96 cDNA||LY96 ELISA Kit|
|LYN||LYN Antibody||LYN Protein||LYN cDNA||LYN ELISA Kit|
|MALT1||MALT1 Antibody||MALT1 Protein||MALT1 cDNA||MALT1 ELISA Kit|
|MAP3K14||MAP3K14 Antibody||MAP3K14 Protein||MAP3K14 cDNA||MAP3K14 ELISA Kit|
|MAP3K7||MAP3K7 Antibody||MAP3K7 Protein||MAP3K7 cDNA||MAP3K7 ELISA Kit|
|MYD88||MYD88 Antibody||MYD88 Protein||MYD88 cDNA||MYD88 ELISA Kit|
|NFKB1||NFKB1 Antibody||NFKB1 Protein||NFKB1 cDNA||NFKB1 ELISA Kit|
|NFKB2||NFKB2 Antibody||NFKB2 Protein||NFKB2 cDNA||NFKB2 ELISA Kit|
|NFKBIA||NFKBIA Antibody||NFKBIA Protein||NFKBIA cDNA||NFKBIA ELISA Kit|
|PARP1||PARP1 Antibody||PARP1 Protein||PARP1 cDNA||PARP1 ELISA Kit|
|PIAS4||PIAS4 Antibody||PIAS4 Protein||PIAS4 cDNA||PIAS4 ELISA Kit|
|PIDD1||PIDD1 Antibody||PIDD1 Protein||PIDD1 cDNA||PIDD1 ELISA Kit|
|PLAU||PLAU Antibody||PLAU Protein||PLAU cDNA||PLAU ELISA Kit|
|PLCG1||PLCG1 Antibody||PLCG1 Protein||PLCG1 cDNA||PLCG1 ELISA Kit|
|PLCG2||PLCG2 Antibody||PLCG2 Protein||PLCG2 cDNA||PLCG2 ELISA Kit|
|PRKCB||PRKCB Antibody||PRKCB Protein||PRKCB cDNA||PRKCB ELISA Kit|
|PRKCQ||PRKCQ Antibody||PRKCQ Protein||PRKCQ cDNA||PRKCQ ELISA Kit|